8-K: Clever Leaves Sells Non-Cannabinoid Business Segment for $8.02 Million

Clever Leaves Holdings Inc. has completed the sale of its non-cannabinoid business segment, Herbal Brands, Inc., for a total of $8.02 million.

Summary

• Clever Leaves Holdings Inc. sold its non-cannabinoid business segment, which includes Herbal Brands, Inc., to KAC Investments LLC.
• The sale was completed on March 21, 2024, for a total purchase price of $8.02 million.
• The purchase price included $7.02 million in cash and a $1 million senior secured promissory note.
• The promissory note accrues interest at 7.5% per annum, payable quarterly, with the principal due on March 21, 2025.
• Clever Leaves also expects to receive an additional $0.19 million from the sale of Herbal Brands' manufacturing equipment.
• The sale agreement includes customary representations, warranties, and post-closing indemnities.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The sale provides cash and allows focus on the core business, but the sale price may be considered low and there is a risk of non-payment of the promissory note.

Positives

• The sale provides Clever Leaves with an immediate cash infusion of $7.02 million.
• The promissory note provides a future income stream with a 7.5% interest rate.
• The sale allows Clever Leaves to focus on its core cannabinoid business.
• The transaction includes a personal guarantee for the promissory note, reducing risk.

Negatives

• The sale represents a divestment of a business segment, potentially reducing overall revenue.
• The promissory note is not due until March 21, 2025, delaying full receipt of the sale proceeds.
• The sale price of $8.02 million may be considered low for a business segment.

Risks

• The buyer's ability to repay the $1 million promissory note is a risk, although it is secured and personally guaranteed.
• The additional $0.19 million from equipment sales is an estimate and may not be fully realized.
• The company will need to manage the transition and ensure the remaining business is not negatively impacted.

Future Outlook

The company will focus on its core cannabinoid business after the sale of the non-cannabinoid segment. The company will receive quarterly interest payments on the promissory note and the principal payment in March 2025.

Industry Context

The sale of the non-cannabinoid business segment suggests a strategic shift for Clever Leaves, focusing on its core cannabis operations. This is a common trend in the industry as companies streamline operations and focus on core competencies.

Comparison to Industry Standards

• The sale of a non-core business segment is a common strategy for companies looking to streamline operations and focus on core competencies.
• The valuation of $8.02 million for the non-cannabinoid business segment is difficult to assess without detailed financial information on the segment's performance.
• Comparable transactions in the cannabis industry often involve complex deal structures, including cash, stock, and earn-out provisions, which this deal does not include.
• The use of a promissory note with a personal guarantee is a common mechanism to provide security in private transactions.

Stakeholder Impact

• Shareholders will see a change in the company's business focus.
• Employees of Herbal Brands will transition to the new owner.
• Customers of Herbal Brands will be served by the new owner.
• Creditors of Clever Leaves may see a slight improvement in the company's financial position.

Next Steps

• Clever Leaves will integrate the cash proceeds into its operations.
• The company will manage the transition of the divested business.
• Clever Leaves will monitor the promissory note and ensure timely payments.

Key Dates

Keywords

Clever Leaves, Herbal Brands, non-cannabinoid, sale, divestment, promissory note, KAC Investments, business segment, acquisition